SCHEMBL4903328

SCHEMBL4903328

NC(=O)c1ccc(Nc2nccc(-c3cccnc3)n2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.81
MAPK10 P53779 1/20 0.81
ABL1 P00519 11/20 0.69
PRKCA P17252 5/20 0.69
PRKCD Q05655 4/20 0.69
EGFR P00533 2/20 0.69
HDAC1 Q13547 1/20 0.67
ACVR1 Q04771 1/20 0.67
GSK3B P49841 2/20 0.64
PIK3CG P48736 1/20 0.64
CAMKK2 Q96RR4 1/20 0.64
BCR P11274 10/20 0.63
CDK4 P11802 1/20 0.62
CDK2 P24941 1/20 0.62
ABL2 P42684 1/20 0.61
SRC P12931 5/20 0.60
PRKACA P17612 1/20 0.60
PRKACG P22612 1/20 0.60
PRKACB P22694 1/20 0.60
IKBKB O14920 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8246523 0.90 MAPK8 (1.00) MAPK8MAPK10ABL1PRKCAPRKCD
SCHEMBL210190 0.88 ABL1 (0.76) MAPK8MAPK10ABL1PRKCAPRKCD
Hydrochloric Acid SCHEMBL7470853 0.87 ABL1 (0.74) MAPK8MAPK10ABL1PRKCAPRKCD
SCHEMBL7467179 0.87 ABL1 (0.69) MAPK8MAPK10ABL1PRKCAPRKCD
SCHEMBL7470849 0.87 ABL1 (0.69) MAPK8MAPK10ABL1PRKCAPRKCD
SCHEMBL4903457 0.87 MAPK8 (0.81) MAPK8MAPK10ABL1HDAC1ACVR1
SCHEMBL4895454 0.86 ABL1 (0.80) MAPK8MAPK10ABL1PRKCAPRKCD
Hydrochloric Acid SCHEMBL27711429 0.85 ABL1 (0.79) MAPK8MAPK10ABL1PRKCAPRKCD
SCHEMBL7474316 0.85 HDAC1 (0.68) MAPK8MAPK10ABL1PRKCAPRKCD
SCHEMBL4073695 0.85 MAPK8 (0.65) MAPK8MAPK10ABL1PRKCAPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US claimed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP claimed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO claimed
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed
CN-101155786-A N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof IL YANG PHARM CO LTD (KR) 2008-04-02 CN disclosed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP disclosed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP MAPK8 3140/4885MAPK10 2491/4885ABL1 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.